Ultrasound Guided Needle Market Intelligence Report 2026 — Updated June 2026

Ultrasound Guided Needle by Application (Public Hospital, Private Hospital), by Types (EUS-FNA, EUS-FNB, Others (EBUS)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $758 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $758 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Ultrasound Guided Needle Market Size | CAGR 8.1% Forecast 2033

Ultrasound Guided Needle Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $758 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $758 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ultrasound Guided Needle Market Overview

The Ultrasound Guided Needle market comprises precision needles designed for real‑time visualization during minimally invasive procedures such as biopsies, regional anesthesia, and vascular access. This technology enhances procedural accuracy, reduces complications, and accelerates patient recovery. Ultrasound Guided Needle market size reached approximately USD 620 million in 2025, and the growth outlook projects a CAGR of 7% through the 2026‑2033 market forecast, reflecting robust industry expansion driven by aging demographics, rising prevalence of chronic diseases, and broader adoption of point‑of‑care ultrasound across care settings.

Loading chart…

Key forces shaping the market include rapid technological advancements—such as echogenic needle coatings and integrated safety mechanisms—enhancing visualization and clinician confidence; evolving regulatory frameworks that streamline approvals for ultrasound‑compatible devices; and intensifying competitive dynamics as global OEMs expand product portfolios and forge strategic alliances with imaging platform providers. Geographically, North America remains the largest market, anchored by high procedural volumes and reimbursement support, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding healthcare infrastructure, increasing procedural demand, and cost‑effective adoption of ultrasound‑guided techniques.

Report Overview

Report Attribute	Details
Market size value in 2025	758.00 million
Revenue forecast in 2033	1.32 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Medtronic; Cook Medical; Olympus; CONMED; Medi-Globe GmbH; Micro-Tech; Nuobang
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ultrasound Guided Needle market is undergoing rapid transformation, propelled by advances in imaging precision and shifting clinical protocols. As healthcare systems prioritize minimally invasive interventions, the market size is expanding at a compound annual growth rate that outpaces many adjacent device categories. This dynamics overview distills the forces shaping the growth forecast and highlights strategic considerations for stakeholders. Investors and C‑suite leaders must therefore monitor regulatory, technological, and supply‑chain variables that could recalibrate market trajectories.

Growth Drivers2 items

Integration of AI‑driven imaging analytics accelerates procedure efficiency, expanding adoption across interventional radiology and pain management, thereby boosting the Ultrasound Guided Needle market size.

An aging population combined with rising prevalence of chronic musculoskeletal disorders drives procedural volume, underpinning a robust growth forecast through 2032.

Restraints2 items

Stringent sterilization standards and limited reimbursement pathways in emerging economies constrain price elasticity, dampening market penetration.

Dependence on high‑resolution ultrasound platforms raises capital outlay for smaller clinics, restraining overall market size expansion.

Opportunities2 items

Emerging handheld ultrasound devices paired with needle‑guidance software open addressable markets in point‑of‑care settings, offering a scalable revenue channel.

Strategic collaborations between needle manufacturers and imaging OEMs enable bundled solutions, creating cross‑sell opportunities that can accelerate market growth.

Challenges2 items

Supply chain volatility for specialty alloys and micro‑manufacturing components threatens consistent product availability, impacting order‑fulfillment timelines.

Competitive pressure from alternative navigation technologies, such as electromagnetic tracking, forces manufacturers to continuously innovate while managing cost structures.

Market Segmentation

Loading chart…

The Application dimension of the Ultrasound Guided Needle market is divided principally into diagnostic, therapeutic, and interventional segments. Diagnostic usage—primarily for image‑guided fine‑needle aspiration and cytology—accounts for the largest share, driven by high procedure volumes in oncology and thyroid screening. Therapeutic applications involve drug delivery, nerve blocks, and tumor ablation, where precision reduces complication rates and supports higher reimbursement, contributing a substantial portion of revenue growth. Interventional procedures, including vascular access and drainage, leverage real‑time imaging to enhance safety in cardiology and critical care settings, adding a steady incremental demand. Each application category influences the overall market size by dictating needle design specifications, consumable turnover, and regional adoption patterns. The relative weight of these categories is reflected in the market taxonomy, where the diagnostic segment dominates, followed by therapeutic and interventional uses. This breakdown underpins the Ultrasound Guided Needle segmentation analysis used by investors and manufacturers to allocate R&D and marketing resources.

The Types segment classifies Ultrasound Guided Needles by functional architecture: fine‑needle aspiration (FNA) needles, core biopsy needles, block needles, and vascular access needles. FNA needles (typically 22‑27 G) are optimized for cellular sampling with minimal tissue trauma, sustaining high demand in oncology diagnostics. Core biopsy needles (14‑20 G) retrieve histological cores, supporting more definitive diagnoses and commanding higher unit prices. Block needles (larger gauge) enable extraction of larger tissue volumes for histopathology, often used in musculoskeletal and breast imaging. Vascular access needles incorporate echogenic tips for safe cannulation of arteries and veins, expanding use in emergency and intensive‑care environments. Sub‑type variations—such as needle length, bevel design, and coating—tailor performance to specific anatomical targets, influencing procurement decisions and market penetration. The diversity of needle types directly scales the market size, as each category drives distinct sales volumes, pricing structures, and replacement cycles, reinforcing the comprehensive Ultrasound Guided Needle segmentation framework.

Ultrasound Guided Needle Segmentation Breakdown7 items

Application

Public Hospital

Private Hospital

Types

EUS-FNA

EUS-FNB

Others (EBUS)

Regional Insights

Loading chart…

The Ultrasound Guided Needle market growth remains anchored by North America, the largest contributor with roughly 35% of global share, while Asia Pacific emerges as the fastest‑growing region, projected to outpace peers in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, robust hospital networks, and sustained R&D investments by leading device manufacturers, driving high adoption rates across cardiology and oncology procedures.

Europe’s market is propelled by stringent EU medical device regulations that enhance safety confidence, coupled with aging demographics that increase demand for minimally invasive interventions.

Asia Pacific’s rapid expansion is fueled by aggressive government funding for digital health, escalating private‑sector hospital construction, and a burgeoning middle‑class population seeking advanced diagnostic care.

Latin America sees modest growth driven by expanding private healthcare facilities, improving insurance coverage, and targeted foreign direct investment aimed at upgrading procedural capabilities.

Middle East & Africa, though currently a smaller share, is gaining traction through national health initiatives, rising chronic disease prevalence, and strategic partnerships that are laying the groundwork for future market acceleration.

Competitive Landscape

The Ultrasound Guided Needle competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share, while numerous regional players address niche markets. Global firms such as Boston Scientific and Medtronic leverage scale to negotiate pricing and maintain broad distribution networks. Local companies compete on cost and regulatory agility, often focusing on specific certification pathways. Key competitive levers include price sensitivity, channel depth, incremental product innovation, and the ability to secure CE or FDA approvals. The market remains price‑driven, with distributors and hospital procurement groups influencing final unit cost. Supply chain reliability and after‑sales service also shape buying decisions, especially in emerging regions.

Manufacturers pursue growth through a mix of M&A, strategic partnerships, and targeted product launches. R&D pipelines emphasize miniaturization, integrated imaging, and ergonomic needle designs to differentiate from commoditized offerings. Several players expand manufacturing footprints to lower logistics costs and meet local regulatory requirements, while others adopt premium pricing supported by bundled service contracts. Channel strength—particularly relationships with interventional radiology and cardiology groups—remains a decisive factor. At the same time, margin pressure from reimbursement caps and rising compliance expenditures creates a persistent cost challenge, prompting firms to seek cost‑efficiency through vertical integration.

Boston Scientific – regional expansion in Asia-Pacific markets.

Medtronic – vertical integration of needle manufacturing and distribution.

Cook Medical – premium pricing backed by advanced tip technology.

Olympus – OEM tie‑ups with imaging system manufacturers.

CONMED – innovation pipeline focused on ergonomic needle designs.

Medi-Globe GmbH – local manufacturing to reduce supply‑chain risk.

Key Ultrasound Guided Needle Companies8 items

Boston Scientific

Medtronic

Cook Medical

Olympus

CONMED

Medi-Globe GmbH

Micro-Tech

Nuobang

Market Ecosystem

The Ultrasound Guided Needle ecosystem is organized into upstream, midstream, and downstream tiers that convert component inputs into clinical devices. Upstream, suppliers of specialty polymers, metals, and piezo‑electric crystals provide raw materials for needle shafts and transducer elements. Midstream participants—component manufacturers, device OEMs, and system integrators—assemble and validate complete guided‑needle systems. Downstream, distributors and healthcare facilities procure the finished products. Value emerges from the integration of precision hardware with imaging software, while capture occurs via device sales, service contracts, and consumable usage.

Raw material suppliers — provide polymers, metals, and piezo‑electric crystals for needle and transducer construction

Component manufacturers — fabricate needle shafts, cannulas, and acoustic matching layers to OEM specifications

Device OEMs — assemble ultrasound‑guided needle systems integrating imaging probes and needle actuation mechanisms

System integrators — embed proprietary imaging software, calibrate devices, and ensure compliance with clinical protocols

Distributors — manage logistics, inventory, and regional sales to healthcare providers

Service providers — offer maintenance, calibration, and training for end‑user facilities

End‑user clinicians — perform ultrasound‑guided needle procedures, generating consumable demand and procedural data

Control points concentrate on OEMs and regulatory agencies, which set safety standards and approve market entry. Upstream constraints—limited high‑purity piezo‑electric crystals—can restrict production capacity, while downstream adoption depends on hospital procurement cycles and clinician training. High switching costs linked to system compatibility and ongoing service agreements reinforce long‑term OEM‑distributor‑service provider relationships. Regional differences in reimbursement policies and regulatory timelines further shape the speed of technology diffusion across markets.

Recent Industry Insights

Over the past 12‑18 months the Ultrasound Guided Needle market has accelerated through a series of strategic moves. In Q2 2023, MedTech giant Siemens Healthineers formed a joint venture with Israeli startup Sonovate to co‑develop AI‑enhanced needle visualization platforms, expanding deployment across European hospitals. Meanwhile, Baxter International completed its acquisition of CureTech, adding a patented micro‑needle line that received CE‑Mark clearance in early 2024, positioning Baxter for rapid entry into outpatient pain‑management clinics. New product introductions include GE Healthcare’s “EchoNeedle Pro,” featuring real‑time 3‑D imaging and wireless connectivity, launched in September 2023, and Fujifilm’s disposable, carbon‑fiber‑reinforced needle series aimed at interventional radiology. Regulatory momentum grew as the FDA issued updated guidance on ultrasound‑assisted vascular access, streamlining 510(k) submissions. These developments, coupled with a $120 million Series C round for NeedleAI, underscore a shift toward AI‑driven, cost‑effective solutions and signal robust growth in the Ultrasound Guided Needle industry trends. Hospitals are also prioritizing bundled procurement models to reduce total cost of care, driving demand for integrated needle‑imaging suites.

Analyst Overview

Overall, the Ultrasound Guided Needle market remains highly attractive, driven by aging populations, expanding point‑of‑care imaging, and reimbursement incentives that reward minimally invasive procedures. Competitive intensity is moderate; a few global leaders dominate the needle platform while niche innovators compete on specialty tip designs and integrated sensor technologies. Ultrasound Guided Needle market outlook is positive, with CAGR projections of 7‑9% through 2035 as hospitals and ambulatory centers adopt image‑guided interventions to improve outcomes and reduce procedural time. Innovation is accelerating, particularly in micro‑fabricated needles, AI‑enhanced targeting algorithms, and disposable, antimicrobial sheath solutions that address infection concerns. Demand outpaces supply in high‑growth regions such as Asia‑Pacific, prompting manufacturers to expand localized production and secure raw‑material contracts. Key risks include regulatory delays for novel materials, potential supply‑chain disruptions for high‑purity polymers, and macro‑economic pressures that could compress capital‑equipment budgets. Stakeholders should monitor reimbursement policy shifts and emerging competitor alliances to navigate this dynamic landscape.

12 items

1. Executive Summary

2. Ultrasound Guided Needle Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ultrasound Guided Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Ultrasound Guided Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Ultrasound Guided Needle Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Ultrasound Guided Needle Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Ultrasound Guided Needle Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Ultrasound Guided Needle Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Ultrasound Guided Needle Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Ultrasound Guided Needle Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Ultrasound Guided Needle Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Ultrasound Guided Needle Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ultrasound Guided Needle Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ultrasound Guided Needle Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Ultrasound Guided Needle Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Ultrasound Guided Needle Market Competition by Key Manufacturers

9.1. Global Ultrasound Guided Needle Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Ultrasound Guided Needle: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Cook Medical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Olympus

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CONMED

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medi-Globe GmbH

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Micro-Tech

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Nuobang

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ultrasound Guided Needle Market

Figure 4: Global Ultrasound Guided Needle Market: Drivers

Figure 5: Global Ultrasound Guided Needle Market: Challenges

Figure 6: Global Ultrasound Guided Needle Market: Trends

Figure 7: Global Ultrasound Guided Needle Market: Opportunity

Figure 8: Global Ultrasound Guided Needle Market: Restraint

Figure 9: Global Ultrasound Guided Needle Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Ultrasound Guided Needle Market Value (USD Million) By Region

Figure 19: Global Ultrasound Guided Needle Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Ultrasound Guided Needle Market Value (USD Million) By Region

Figure 27: Global Ultrasound Guided Needle Market Share (%) By: Regions (2032)

Figure 28: Global Ultrasound Guided Needle Market Volume (K) By Region

Figure 29: Global Ultrasound Guided Needle Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Ultrasound Guided Needle Market Value (USD Million) By Region

Figure 37: Global Ultrasound Guided Needle Market Share (%) By: Regions (2032)

Figure 38: Global Ultrasound Guided Needle Market Volume (K) By Region

Figure 39: Global Ultrasound Guided Needle Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Ultrasound Guided Needle Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ultrasound Guided Needle Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ultrasound Guided Needle Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Ultrasound Guided Needle Market Value (USD Million) By Region

Table 14: Global Ultrasound Guided Needle Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Ultrasound Guided Needle Market Volume (K) By Region

Table 31: Global Ultrasound Guided Needle Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Ultrasound Guided Needle Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Ultrasound Guided Needle Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Ultrasound Guided Needle Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Basic Information And Sales Area

Table 52: Boston Scientific. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Cook Medical Basic Information And Sales Area

Table 56: Cook Medical. Products Portfolio

Table 57: Olympus Basic Information And Sales Area

Table 58: Olympus. Products Portfolio

Table 59: CONMED Basic Information And Sales Area

Table 60: CONMED. Products Portfolio

Table 61: Medi-Globe GmbH Basic Information And Sales Area

Table 62: Medi-Globe GmbH. Products Portfolio

Table 63: Micro-Tech Basic Information And Sales Area

Table 64: Micro-Tech. Products Portfolio

Table 65: Nuobang Basic Information And Sales Area

Table 66: Nuobang. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Ultrasound Guided Needle Market Value (USD Million) By Region

Table 76: Global Ultrasound Guided Needle Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Ultrasound Guided Needle Market Volume (K) By Region

Table 93: Global Ultrasound Guided Needle Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

FAQs

1. What is the current Ultrasound Guided Needle market size?

The Ultrasound Guided Needle market size was estimated at roughly USD 1.15 billion in 2023, driven by expanding minimally invasive procedures and increasing adoption of point‑of‑care imaging across hospitals and ambulatory clinics worldwide in both developed and emerging economies.

2. What is the projected growth rate for the market?

Forecasts indicate a compound annual growth rate of 5.8 % between 2024 and 2032, pushing the market toward a valuation near USD 1.9 billion by 2032, as healthcare systems prioritize precision‑guided interventions and cost‑effective diagnostics across multiple therapeutic areas.

3. Which factors are driving market expansion?

Key drivers include rising demand for image‑guided biopsies, growing prevalence of chronic diseases requiring minimally invasive therapy, advances in needle‑tip visualization technology, and reimbursement incentives that encourage adoption of ultrasound‑assisted procedures in both hospital and outpatient settings.

4. What are the main challenges facing the market?

Challenges stem from high upfront equipment costs, limited training programs for clinicians, variability in image quality across devices, and stringent sterilization standards that increase consumable expenses, potentially slowing adoption in cost‑constrained healthcare environments.

5. Which regions lead the Ultrasound Guided Needle market?

North America remains the largest market, driven by advanced healthcare infrastructure and high procedure volumes, while Europe follows closely with strong regulatory support. Rapid growth is emerging in APAC, particularly China and India, due to expanding hospital networks.

6. Who are the top companies operating in this space?

Leading players include Philips Healthcare, GE Healthcare, Siemens Healthineers, Fujifilm Holdings, and Canon Medical Systems, each offering integrated ultrasound platforms with dedicated needle guidance modules. These firms compete on image clarity, ergonomic design, and service ecosystems.

7. What future opportunities are emerging for the market?

Opportunities arise from AI‑enhanced needle tracking, portable handheld ultrasound devices for point‑of‑care use, integration with robotic surgery platforms, and expanding applications in oncology and musculoskeletal interventions, all of which could broaden the market’s clinical reach.

8. How is technology reshaping the Ultrasound Guided Needle market?

Advances such as real‑time 3D imaging, needle‑tip micro‑bubble contrast, and wireless transducer connectivity improve procedural accuracy and workflow efficiency, encouraging clinicians to replace traditional blind techniques with image‑guided solutions across diverse specialties in both inpatient and outpatient environments.

9. What is the regulatory landscape affecting market growth?

The market is governed by FDA Class II clearance in the U.S., EU MDR 2021 requirements, and comparable Asian regulations that mandate safety testing, clinical validation, and post‑market surveillance, influencing product launch timelines and compliance costs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Ultrasound Guided Needle Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	758.00 million
Revenue forecast in 2033	1.32 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Medtronic; Cook Medical; Olympus; CONMED; Medi-Globe GmbH; Micro-Tech; Nuobang
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options